BACKGROUND: Previous studies showed that the quantity of the left atrial (LA) periatrial fat tissue predicts recurrence after catheter ablation of atrial fibrillation (AF). We hypothesized that the quality of the LA periatrial fat tissue, measured by the mean computed tomography attenuation, predicts recurrence after AF ablation independent of the quantity of the LA periatrial fat tissue.
O besity is a worldwide epidemic and constitutes a strong risk factor for atrial fibrillation (AF) 1 the most prevalent arrhythmia in humans. Obesity is also independently associated with AF recurrence after catheter ablation. 2 However, the exact mechanism by which obesity is causally related to AF remains unknown. Atrial stretch, oxidative stress, dysregulation of signaling pathways, proinflammatory cytokines, adipocytokines, fat infiltration, and autonomic modulation have been proposed as mechanisms that link obesity with AF. 3, 4, 5, 6 The volume of the epicardial fat tissue is independently associated with AF recurrence after catheter ablation, [7] [8] [9] [10] suggesting that local interactions between the fat tissue and the heart may account for the mechanism of AF. In fact, the volume 11 and the thickness 12 of the periatrial fat tissue are larger in individuals with AF than those of healthy subjects. The quality of the fat tissue, measured by the mean computed tomography (CT) attenuation (ranges between −45 and −195 Hounsfield units [HU]), 13 is associated with cardiovascular adverse outcomes. For instance, visceral fat attenuation predicts adverse cardiovascular events independently of the fat volume. 14 In addition, higher fat attenuation in the perivascular cardiac tissue is a strong marker of tissue inflammation by histology and positron emission tomography scan and is associated with coronary plaque obstruction and plaque instability independently of the fat volume. 15 Furthermore, subcutaneous fat attenuation is associated with incident metabolic risk factors beyond overall adiposity. 16 The aim of the present work was to investigate the relationship between the quality of the periatrial fat tissue and AF. We hypothesized that the quality of the left atrial (LA) periatrial fat tissue is an independent predictor of recurrence after catheter ablation of AF. To test the hypothesis, we studied the association between the quality of the LA periatrial fat tissue in the preablation cardiac CT and clinical outcomes in patients with either paroxysmal or persistent AF who were referred for the first catheter ablation of AF.
METHODS
Because of the sensitive nature of the data collected for this study, requests to access the dataset will not be allowed given the fact that this request is not included in the protocol that was approved by the institutional review board of our institution.
Study Population
Consecutive patients with symptomatic, drug-refractory AF referred for catheter ablation of AF at the Johns Hopkins Hospital between January 2012 and January 2017 who underwent preprocedural CT were included. Patients who had prior AF ablation or surgical procedure in the LA were excluded. A total of 143 patients were included in the final analysis. Table 1 summarizes the baseline characteristics. The protocol was approved by the institutional review board, and all the patients provided written informed consent.
CT Protocol
Images were acquired using a 320-detector CT scanner (Aquilion ONE; Toshiba Medical Systems, Otawara, Japan) ≤1 week before the procedure. Slice thickness was 0.5 mm, and tube voltage was 80, 100, or 120 kV, depending on the body habitus. Tube current ranged from 320 to 580 mA, depending on the body habitus and heart rate. Image acquisition was ECG gated at 40% R-R interval during a breath hold. The contrast protocol included a total volume of 60 mL (70 mL if body mass index [BMI] is >30 kg/m 2 ) of the nonionic low-osmolar iodinated contrast material iopamidol (Isovue 370; Bracco Diagnostics, Princeton, NJ) administered at a rate of 5 mL/s. First-pass images were used for segmentation and analysis.
Image Analysis
The CT images were reconstructed with an in-plane resolution of 0.5×0.5 mm and a through-plane resolution of 3.0 mm with a 1.5-mm gap between slices. The images were transferred to a workstation (Vitrea Advanced Visualization, version 7.7.0; Vital Images) for offline fat analysis. The operator responsible for the imaging analysis was blinded to AF outcomes. The LA periatrial fat measurements were derived from manually segmenting the LA on a single 2-dimensional slice in the standard 4-chamber (4-CH) and 2-chamber (2-CH) views ( Figure 1 ). Contiguous voxels between the HU limits of −200 and −50 were defined as fat voxels, and the mean attenuation of each fat depot was calculated. [14] [15] [16] In addition, the total area of fat (millimeter square) in each region of interest was also calculated. To study the correlation between 2-dimensional and 3-dimensional (3D) fat measurements, the LA periatrial fat was also manually segmented in 3D from the pulmonary artery bifurcation to the diaphragm (Vitrea Advanced Visualization, version 7.7.0; Vital Images; Figure 
CLINICAL PERSPECTIVE
Atrial fibrillation ablation is the indicated treatment for individuals with drug-refractory atrial fibrillation. However, the rate of recurrence after the procedure is relatively high, in part, because of poor patient selection before the intervention. Thus, identifying tools that assist the physician in the selection of adequate candidates is imperative. Our study examined the value of periatrial fat quality in predicting the success of atrial fibrillation ablation beyond traditional risk factors and other indices of left atrial structure and function. Starting from present observations, further prospective studies are needed to determine the direct implications of this novel index in the process of selecting the best candidates to be referred to atrial fibrillation ablation.
Mapping and Ablation
Mapping and ablation of AF were performed using an electroanatomical mapping system with an image integration module to merge preprocedural CT (CARTO and CartoMerge; Biosense Webster, Diamond Bar, CA). A detailed description of the procedure has been described elsewhere. 17 Briefly, all patients underwent the standard pulmonary vein isolation, where electrical isolation of the pulmonary veins was confirmed by a circular multipolar electrode mapping catheter (Lasso; Biosense Webster). In cases of persistent AF, the ablation procedure usually included additional ablation lesions, as described in the Results section. Ablation was performed with either an open-irrigated radiofrequency ablation catheter with or without force sensing (NaviStar, ThermoCool, or ThermoCool SmartTouch; Biosense Webster, Inc, Diamond Bar, CA) or a cryoballoon ablation catheter (Arctic Front Advance; Medtronic, Inc, Minneapolis, MN). A subgroup of patients underwent bipolar voltage mapping during sinus rhythm before pulmonary vein isolation using the electroanatomical mapping system and the ablation catheter with a 3.5mm distal tip and 2-mm interelectrode spacing. Endocardial contact during point acquisition was validated by recording a stable signal for >2 beats.
Follow-Up
AF recurrence was defined as any documented episodes of AF, atrial flutter, or atrial tachycardia lasting >30 seconds after a 3-month blanking period. 18 All medications, including antiarrhythmic and anticoagulation drugs, were continued in all patients during the blanking period. Patients were seen in clinic 10 to 12 weeks after ablation. At the clinic visit, antiarrhythmic and anticoagulation drugs were discontinued at the discretion of the physician according to the patient's stroke risk. Then, the patients were followed by the referring physician on a regular basis. In addition, the patients received direct phone interviews or emails with a standardized questionnaire to report AF symptoms, if any, in detail. Patients were excluded if they were not followed up for at least 1 year after ablation. When recurrence was suspected, the patients underwent a 24-hour Holter monitor or a 30-day cardiac event monitor depending on the symptom frequency.
Statistical Analysis
Baseline patient demographics are presented as mean±SD or percentage and are compared using Student t test, χ 2 , and Fisher test, as appropriate. Multivariable Cox proportional hazards models were used to evaluate the effects of LA total fat area and attenuation on AF recurrence after ablation. Three models are presented: coefficient. Final model goodness of fit was evaluated by using the Cox-Snell residuals on the Nelson-Aalen cumulative hazard function. The model fit was established by visually plotting the function and analyzing if the hazard function follows the 45° line. Our final models mostly followed the 45° angle except for the large values of time, which is mostly because of the censoring effect. Time to first recurrence is presented using Kaplan-Meier curves. A log-rank test was conducted to detect differences in the survival distributions for 2 curves. The 2 curves were generated based on receiver operating characteristic best cut point using Liu criteria. In a subset of randomly selected patients (n=15), intraobserver and interobserver reproducibility was performed, and the intraclass correlation coefficient with a 2-way random model (intraclass correlation coefficient <0.40, poor; intraclass correlation coefficient >0.40-0.75, fair to good; and intraclass correlation coefficient >0.75, excellent agreement) was evaluated. The 0.05 significance level was used for all hypothesis tests, and all t tests were 2 sided. The statistical computations were performed using STATA (version 12.0; StataCorp).
RESULTS

Patient Demographics
A total of 357 patients were selected from our database, who underwent to first catheter ablation to treat AF; of those, 208 underwent to MRI before the procedure, 1 patient (No. 04) had poor contrast opacification of the LA, and 1 patient's (No. 02) images were unavailable; those individuals were excluded from our study.
There were 91 (63.6%) male patients, and the average age was 62.2±10.4 years. Acute pulmonary vein isolation was achieved in all subjects. Seventeen patients (11.9%) had additional ablation lesions beyond pulmonary vein isolation. Thirteen patients (9.1%) had a linear ablation lesion connecting the right and the left superior pulmonary veins (the roofline), and 1 (0.7%) had a linear ablation lesion connecting the coronary sinus and the left inferior pulmonary vein (the mitral isthmus line). One patient (0.8%) underwent both the roof line and the mitral isthmus line. No ablation was performed in the right atrium in any of the patients.
A total of 57 patients developed AF recurrence after ablation (recurrence group), and the remaining 86 patients were free of AF recurrence (control group). Among the subjects who had recurrence, 15 underwent a second procedure and 37 started using antiarrhythmic drug; 7 subjects without recurrence started using antiarrhythmic drug. Compared with the control group, more patients in the recurrence group were on calcium channel blockers before ablation (P=0.037). The patients in the recurrence group were also more likely to have a history of hypertension, heart failure, obstructive sleep apnea, and persistent AF than those of the control group. A total of 48 patients (33.5%) in the final analysis had bipolar voltage mapping available during sinus rhythm. Except for the age and history of paroxysmal AF, which were both higher in the voltage mapping subgroup, all other clinical characteristics were similar to the entire cohort.
LA Fat Attenuation and Recurrence
Our analysis showed an excellent intrareader and interreader reproducibility. The intrareader reproducibility ranged from 0.92 (area: confidence interval, 0.89-0.94; P=0.003) to 0.96 (attenuation: confidence interval, 0.95-0.97; P<0.001), and the interreader reproducibility ranged from 0.87 (area: confidence interval, 0.84-0.90; P=0.005) to 0.91 (attenuation: confidence interval, 0.87-0.93; P=0.005). Patients in the recurrence group had significantly larger LA dimension (5.8 versus 5.2 cm; P=0.038), larger 4-CH LA periatrial fat area (167.6 versus 145.4 mm 2 ; P=0.018), and lower attenuation (−96.5 versus −92.0 HU; P=0.006) compared with control ( Table 2) . There was no significant difference in the 2-CH LA periatrial fat area or attenuation between the recurrence and the control groups (P=0.328). The 4-CH LA periatrial fat area (millimeter square, y axis) and the 4-CH LA periatrial fat attenuation (HU, x axis) were significantly correlated with the correlation coefficient of 0.51 (P<0.001; Figure 2 ). The 4-CH LA periatrial fat attenuation was associated with AF recurrence (Figure 3) . The correlation coefficient was 0.40 (P=0.001) between the 4-CH 
Multivariable Analyses
In model 1, univariable (unadjusted) analysis identified BMI, AF type, LA periatrial fat area, and attenua-tion as contributors of AF recurrence ( Table 3 ). We also performed a sensitivity analysis excluding the subjects who underwent additional procedures (n=17), and the values of HR for the unadjusted (HR, 1.03; P=0.023) and adjust- 
DISCUSSION
Main Findings
To our knowledge, this is the first study to investigate the association between the quality of the LA periatrial fat tissue and clinical outcomes after AF ablation. We found that the LA periatrial fat attenuation was an independent predictor of AF recurrence. In addition, we demonstrate that the simple measurement of LA periatrial fat in a single 4-CH view alone is sufficient to predict the clinical outcome.
LA Fat Inflammation and Ablation Outcomes
Several studies have demonstrated the heterogeneity of fat characteristics and distribution through the body. 4, 5, 13, 15, 19 Indeed, periatrial epicardial fat may be an atypical adipose tissue with distinct characteristics compared with periventricular or pericoronary epicardial fat. 19 In experimental models, only the periatrial fat was able to express genes implicated in oxidative phosphorylation, muscular contraction, and calcium signaling. 19 The fat attenuation by CT reflects the tissue quality and has been demonstrated to be correlated with the degree of inflammation (by histology and positron emission tomog-raphy scan) and adipocyte differentiation in pericoronary tissue. 15 An emerging concept of the bidirectional interaction between the endothelial and fat tissue highlights the effect of the endothelium in promoting fat inflammation by releasing paracrine factors such as IL-6, TNF-α, and IFN-γ, which alters the adipocyte differentiation and induces lymphocyte migration. In Individuals with AF, periatrial epicardial fat showed a significant positive association with increased levels of sICAM-1 (soluble intercellular adhesion molecule 1) and von Willebrand factor, which are biomarkers of endothelial dysfunction. Interestingly, BMI and total pericardial fat were not associated with inflammatory factors in the same population, suggesting that the local fat instead of the total fat content modulates the endothelial dysfunction in patients with AF. 12 In fact, atrial biopsies from patients with AF have shown the infiltration of inflammatory cells. 20 Furthermore, individuals with AF presented higher levels of inflammatory cytokines in the LA than in the periphery. 21 It is possible that the level of attenuation by CT represents a marker of tissue activity and unfavorable outcomes because of elevated inflammation, edema that precludes proper ablation lesion formation by modifying the tissue intrinsic characteristics including impedance and conductivity.
Obesity, Periatrial Fat Attenuation, and AF Recurrence
In our recent work, we found that BMI is an independent predictor of AF recurrence after ablation. 22 In con- trast, our results indicate that BMI was not significantly associated with AF outcomes after adjusting for other clinical risk factors (Table 3 ). This apparent contradiction is explained by an equal distribution of obesity in both the recurrence (BMI, 33.3±8.2) and the control groups (BMI, 31.7+6.5), and there was no significant difference between those 2 groups (P=0.195; Table 1 ). The present article complements the article by Sivasambu et al in 3 aspects. First, our results confirm that LA periatrial fat area is not necessarily associated with BMI. This finding is consistent with our previous report that BMI was not associated with the volume of the periatrial fat tissue. 23 Those findings can be explained by the focused distribution of the periatrial fat tissue out of proportion to the total fat in the body. 12, 20, 21, 24 The clinical significance of the local distribution, rather than the total amount, of the fat tissue in predicting adverse events has been recognized as the obese mortality paradox in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation 25 and ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation), 26 where BMI represented a protector factor for the mortality in individuals with AF. Second, our results show that the quality, or attenuation, of the periatrial fat tissue is more important than the quantity. Previous studies showed that the volume of the periatrial fat tissue is important in predicting AF recurrence after catheter ablation. 10 In our study, although the LA periatrial fat area was higher in the recurrence group, multivariable analysis showed that the LA periatrial fat area was not an independent predictor of recurrence. This finding suggests that the quality of the fat tissue may accurately reflect the level of stress to which the chamber is exposed, therefore, representing a better surrogate of LA remodeling. Third, our results indicate that LA periatrial fat quantification identifies a high-risk subgroup who is resistant to AF ablation even among the obese individuals.
4-CH Versus 2-CH Views and Ablation Outcomes
A previous study showed that the periatrial fat pad between the mid-LA and esophagus was significantly associated with AF and AF burden (paroxysmal versus persistent AF). 24 However, the same study did not show a significant association of AF or AF burden with periatrial fat between mid-LA and pulmonary artery or between mid-LA and thoracic aorta. This study highlights the critical importance of the periatrial fat pad in the mid-LA and esophagus region, which is captured by the 4-CH view (green arrow in Figure 1 ). This finding likely explains why the fat pad quantification in the 4-CH view is a better marker of recurrence than that of the 2-CH view. Another potential reason to account for the difference in our findings between the 2-CH and the 4-CH views is the partial volume effect. In our recon-structed image, the 2-CH view is more prone to the partial volume effect because of the poorer through-plane resolution compared with the in-plane resolution. In contrast, the 4-CH view has the minimal partial volume effect because of the through-plane resolution because it is essentially a slightly off-axis transverse image. This partial volume effect may also explain, at least partially, why the LA fat attenuation in the 2-CH view was higher than that of the 4-CH view.
Clinical Implications
Catheter ablation of AF remains far from curative, with recurrence rates ≤40%. 27 Measurement of the quantity and the quality of the LA periatrial fat tissue by cardiac CT is a relatively simple method to quantify the degree of inflamed fat and to identify candidates who are responsive to catheter ablation. Our results clearly indicate that the periatrial fat attenuation value over −86.98 HU is a significant predictor of AF recurrence independent of clinical risk factors and LA structure. This simple parameter could improve patient selection and thus reduce recurrence by saving candidates with higher degrees of LA remodeling from futile procedures and potential procedural complications. LA periatrial fat attenuation measurements on a single 2-dimensional slice in the standard 4-CH view is simple, and thus incorporating it into routine clinical practice is relatively straightforward, unlike LA fibrosis quantification by MRI, which requires extensive postprocessing. 28 
Limitations
This study represents a single-center analysis of patients referred for catheter ablation of AF; therefore, there is a non-negligible chance of selection bias. Our definition of recurrence was strongly influenced by symptoms. Therefore, it is possible that we could have missed recurrence that is completely asymptomatic. For fat analysis, we used only 2-CH and 4-CH views. Therefore, it is possible that our analysis underestimated the degree of LA fat by missing regions that were not covered by those 2 views. The current study evaluated the outcomes ≤12 months after ablation. Further studies will be necessary to evaluate the impact of periatrial fat on late recurrence beyond 12 months. Despite these potential causes of underestimation, our analysis demonstrated a significant association between LA quality and AF recurrence. Moreover, 2-dimensional LA fat was significantly correlated with 3D fat. Therefore, we think that the advantage of our approach outweighs the disadvantage of including more views to assess the whole LA fat, which would increase the scan time and postprocessing burden. Furthermore, our study lacks external validation outside the population that was included in our analysis. Last, this is an observational study, and despite rigorous statistical adjustments, unmeasured confounding cannot be excluded.
Conclusions
The quality of the LA periatrial fat tissue, measured by CT attenuation, is an independent predictor of recurrence after the first catheter ablation of paroxysmal or persistent AF. The quality of the LA periatrial fat tissue is a relatively simple metric to quantify the degree of underlying LA remodeling to identify candidates who are responsive to catheter ablation. Therefore, assessment of LA periatrial fat attenuation can improve ablation outcomes by refining patient selection.
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